Aster India reports strong revenue and EBITDA performance. H1 FY25 revenues up 18% YoY to INR 2,088 Crs; H1 FY25 Operating EBITDA up 44% YoY to INR 410 Crs Q2 FY25 revenues up 16% YoY to Rs. 1,086 Crs.; Op. EBITDA grew 48% to Rs. 233
~Currently operates 9 satellite labs and 75 patient experience centres~ ~A total of 20 satellite labs will be operational across the country by mid-2022~ Aster Labs, the diagnostic wing of Aster DM Healthcare, a leading healthcare service provider in the country, continues to amplify its presence in